GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the TRIUMPH thing finally clicked for me and I want to write it down — 44 comments in the full submission. View in context.
4.5k
c/retatrutide·submitted 10 months ago by u/source_or_silence

the TRIUMPH thing finally clicked for me and I want to write it down

Resultsbranch of 9 comments

Right, the triple agonist question again, but with numbers this time. I have 15 data points over 16 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 44 comments →

This branch

9 comments, started 10 months ago
u/lina_bruun0 points·10 months ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/sena_teixeira1 point·10 months ago

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/emil_wojcik1 point·10 months ago·edited

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/bilal_osei1 point·10 months ago

phase 2 numbers are not maintenance numbers, cite the trial

replysharereportpermalink
u/iman_castellanos1 point·10 months ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
[deleted]1 point·10 months ago

[deleted]

replysharereportpermalink
u/honest_syringe_20251 point·10 months ago

phase 2 numbers are not maintenance numbers, cite the trial

Adding to this: triple agonist is doing more work than the comment implies.

replysharereportpermalink
u/jarno_cabrera1 point·10 months ago

the weight curves are unusually steep, which makes predicting individual response harder

replysharereportpermalink
u/source_or_silenceOP1 point·10 months ago

Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →